KB195: Clinical Trials

1 trial of KB195, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow KB195: new trials by email Literature Review of KB195 trials Research Report on KB195

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder
KB195 - Urea Cycle Disorder
Phase 2TerminatedKaleido Biosciences132019-09-172022-01-25

Conditions studied

Ornithine Carbamoyltransferase Deficiency Disease (1)  ·  Urea Cycle Disorders, Inborn (1)

Sponsors

Kaleido Biosciences (1)

Countries

Belgium (1)  ·  Germany (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Mark Wingertzahn, PhD (1)